ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,669, issued on June 3, was assigned to Pfizer Inc. (New York).
"GLP-1 receptor agonists and uses thereof" was invented by Gary Erik Aspnes (Biberach an der Riss, Germany), Scott W. Bagley (Voluntown, Conn.), John M. Curto (Mystic, Conn.), Matthew S. Dowling (Old Lyme, Conn.), David Edmonds (Basel, Switzerland), Mark E. Flanagan (Gales Ferry, Conn.), Kentaro Futatsugi (Sharon, Mass.), David A. Griffith (Sudbury, Mass.), Kim Huard (Berkeley, Calif.), Gajendra Ingle (New Haven, Conn.), Wenhua Jiao (Salem, Conn.), Chris Limberakis (Pawcatuck, Conn.), Alan M. Mathiowetz (Waltham, Mass.), David W. Piotrowski (Waterford, Conn.) and Roger B. Ruggeri (Waterford, Conn.).
According to the ab...